M.D. Specialty
Practice Area
We have >10 years of M.D. Specialty Practice Retained Search and Recruiting experience in addition to the breadth of our 20+ years of specialized Pharma & Biotech Search and Recruiting experience.
M.D. Search Experience
Our experience includes filling vital M.D. positions for Pharma & Biotech Companies at various stages of clinical development and commercialization for their drug therapies to treat indications in several therapeutic areas.
Preclinical-stage companies
advancing lead discoveries towards FIH studies
Early-stage Clinical Development Companies
starting/continuing Phase 1-Phase 2/PoC studies
Later-stage Clinical Development Companies
starting/continuing Phase 3 registrational studies
Commercial stage Companies
including small, midsized, and large pharmas and biotechs
Generic Companies
developing branded small and large molecule therapies
Chief Medical Officers
Therapeutic Area Heads
VPs, Clinical Research and/or Development
VPs, Medical Affairs
Executive Medical Directors*
Sr. Medical Directors*
Medical Directors
(Directors and Associate Medical Directors)
*Includes Global Program Leaders, Global Study Leaders,
Clinical Program Leaders, and Clinical Study Leaders among others
Oncology, Hematology, and Immuno-oncology
Neurology
Infectious Diseases
Rare Diseases (genetic and neurological diseases/disorders)
Small and large molecules
Antibody-Drug Conjugates/ADCs
Bispecific Antibodies
Cell Therapies
Gene Therapies
Stem Cell Therapies
A Sampling of M.D. Search and Recruitment Assignments Filled
Early development-stage biotech developing Cancer Stem Cell Therapies
Early development-stage biotech developing Cellular Immunotherapies utilizing Tumor Infiltrating Lymphocytes/TILS Medical Technology
Later-stage development biotech developing multiple Autologous Stem Cell Therapies
Global Head of Oncology Clinical Development for a global pharma’s Oncology Therapeutic Area/TA (a Top 20 Global Oncology Business)
Global Head of Oncology Medical Affairs for a Top 25 global oncology company (company’s first Global Head of Medical Affairs)
Head of Clinical Development for a later-stage Oncology Company Developing an Oncology Product for its 1st NDA Filing (subsequently received FDA approval)
Head of Clinical Development reporting to the CMO for this early-stage biotech developing therapies to treat multiple Rare Genetic Diseases
Clinical Development Head reporting to CMO leading the development of both early and late-stage respiratory therapies
Head of Immuno-oncology reporting to the CMO leading the development of Bispecific Antibody Therapies to treat multiple cancers
Head of US Medical Affairs for a Top 20 Global Oncology Company (first US Head hired into this newly created role)
Early Immuno-oncology/IO Clinical Development Team Leader for a Top 5 Global IO Company (Leading a team of 8+ M.D.s focused on FIH-PoC Clinical Development)
Early-stage Oncology Company developing multiple Bispecific Antibody Therapies to treat multiple cancers
Leading an initial team of 6+ MDs responsible for later-stage clinical development of multiple novel therapies to treat rare neuromuscular diseases and disorders
Leading Global Medical Affairs for a blockbuster Immuno-oncology/IO Product with multiple FDA Breakthrough Therapy Designations
Clinical Development of novel early-stage oncology gene therapies
Clinical Development of novel early-stage oncology cell therapies
Clinical Development of early-stage Immuno-oncology/IO combination therapies
Clinical Development of later-stage novel breast cancer therapies
Clinical Development of early-stage therapies to treat rare genetic neuromuscular autoimmune diseases and disorders
Reporting to a Global Clinical Leader/GCL, and a member of Global Development Team developing novel Immuno-oncology/IO mono and combination cancer therapies
